Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats

NeuroReport

Volumn 10, Issue 4, 1999, Pages 707-711

  Kask, Ants ^a   Pähkla, Rein ^a   Irs, Alar ^a   Rägo, Lembit ^a   Wikberg, Jarl E S ^b   Schiöth, Helgi B ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Food intake; HS014; Leptin resistance; MC4 antagonist; Melanocortin (MC) receptor subtypes; Obesity

Indexed keywords

INTERMEDIN DERIVATIVE; MELANOCORTIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY FAT; DOSE TIME EFFECT RELATION; DRUG EFFECT; EATING HABIT; GLUCOSE BLOOD LEVEL; HYPERPHAGIA; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; WEIGHT GAIN;

EID: 0033577175     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199903170-00009     Document Type: Article

References (24)

1. 1. Panksepp J, Heilly P, Bishop P et al. Pharmacol Biochem Behav 5(Suppl 1), 59-64 (1976).
2. 2. Poggioli H, Vergoni AV and Bertolini A. Peptides 7, 843-848 (1986).
3. 3. Thiele TE, van Dijk G, Yagaloff KA et al. Am J Physiol 274, R248-R254 (1998).
4. 4. Fan W, Boston BA, Kesterson RA et al. Nature 385, 165-168 (1997).
5. 5. Kim E, Welch CC, Grace MK et al. Am J Physiol 270, R1019-R1024 (1996).
6. 6. Brady LS, Smith MA, Gold PW et al. Neuroendocrinology 5, 441-447 (1990).
7. 7. Kask A, Mutulis F, Muceniece R et al. Endocrinology 139, 5006-5014 (1998).
8. 8. Kask A, Rägo L, Mutulis F et al. Biochem Biophys Res Commun 245, 90-93 (1998).
9. 9. Kask A, Rägo L, Wikberg JES et al. Eur J Pharmacol 360, 15-19 (1998).
10. 10. Kask A, Rägo L, Korrovits P et al. Biochem Biophys Res Commun 248, 245-249 (1998).
11. 11. Satoh N, Ogawa Y, Katsuura G et al. Neurosci Lett 224, 149-152 (1997).
12. 12. Seeley RJ, Yagaloff KA, Fisher SL et al. Nature 390, 349 (1997).
13. 13. Huszar D, Lynch CA, Fairchild-Huntress V et al. Cell 88, 131-141 (1997)
14. 14. Krude H, Biebermann H, Luck W et al. Nature Genet 19, 155-157 (1998).
15. 15. Kesterson RA, Huszar D, Lynch CA et al. Mol Endocrinol 11, 630-637 (1997).
16. 16. Schioth HB, Mutulis F, Muceniece R et al. Br J Pharmacol 124, 75-82 (1998).
17. 17. Vergoni AV, Bertolini A, Mutulis F et al. Eur J Pharmacol, in press (1998).
18. 18. Stanley BG, Kyrkouli SE, Lampert S et al. Peptides 7, 1189-1192 (1986).
19. 19. Quillan JM, Sadee W, Wei ET et al. FEBS Lett 428, 59-62 (1998).
20. 20. Rossi M, Kim MS, Morgan DG et al. Endocrinology 139, 4428-4431 (1998).
21. 21. Blum WF and Juul A. Reference ranges of serum leptin levels according to body mass index, gender, and developmental stage. In: Blum WF, Kiess W and Rascher W, eds. Leptin - The Voice of Adipose Tissue. Heidelberg: Johann Ambrosius Barth Verlag, 1997: 318-326.
22. 22. Chua SC, Chung WK, Wupeng XS et al. Science 271, 994-996 (1996).
23. 23. Rothwell NJ and Stock MJ. Obes Res 6, 650-656 (1997).
24. 24. Skuladottir GV, Jonsson L, Skarphedinsson JD et al. Br J Pharmacol 126, 27-34 (1999).